Free Trial

Texas Instruments (TXN) Financials

Texas Instruments logo
$287.80 +2.56 (+0.90%)
Closing price 05/8/2026 04:00 PM Eastern
Extended Trading
$287.30 -0.50 (-0.17%)
As of 05/8/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for Texas Instruments

Annual Income Statements for Texas Instruments

This table shows Texas Instruments' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
2,944 3,551 3,649 5,538 4,986 5,568 7,736 8,710 6,477 4,775 4,973
Consolidated Net Income / (Loss)
2,986 3,595 3,682 5,580 5,017 5,595 7,769 8,749 6,510 4,799 5,001
Net Income / (Loss) Continuing Operations
2,986 3,595 3,682 5,580 5,017 5,595 7,769 8,749 6,510 4,799 5,001
Total Pre-Tax Income
4,216 4,930 6,080 6,686 5,728 6,017 8,919 10,032 7,418 5,453 5,710
Total Operating Income
4,322 4,855 6,083 6,713 5,723 5,894 8,960 10,140 7,331 5,465 6,023
Total Gross Profit
7,575 8,257 9,614 10,277 9,164 9,269 12,376 13,771 11,019 9,094 10,083
Total Revenue
13,000 13,370 14,961 15,784 14,383 14,461 18,344 20,028 17,519 15,641 17,682
Operating Revenue
13,000 13,370 14,961 15,784 14,383 14,461 18,344 20,028 17,519 15,641 17,682
Total Cost of Revenue
5,425 5,113 5,347 5,507 5,219 5,192 5,968 6,257 6,500 6,547 7,599
Operating Cost of Revenue
5,425 5,113 5,347 5,507 5,219 5,192 5,968 6,257 6,500 6,547 7,599
Total Operating Expenses
3,253 3,402 3,531 3,564 3,441 3,375 3,416 3,631 3,688 3,629 4,060
Selling, General & Admin Expense
1,728 1,742 1,694 1,684 1,645 1,647 1,720 1,704 1,825 1,794 1,860
Research & Development Expense
1,267 1,356 1,508 1,559 1,544 1,530 1,554 1,670 1,863 1,959 2,083
Restructuring Charge
258 304 329 321 -36 - - 257 0.00 -124 117
Total Other Income / (Expense), net
-106 75 -3.00 -27 5.00 123 -41 -108 87 -12 -313
Interest Expense
90 80 78 125 170 190 184 214 353 508 543
Other Income / (Expense), net
-16 155 75 98 175 313 143 106 440 496 230
Income Tax Expense
1,230 1,335 2,398 1,106 711 422 1,150 1,283 908 654 709
Preferred Stock Dividends Declared
42 44 33 42 31 27 33 39 33 24 28
Basic Earnings per Share
$2.86 $3.54 $3.68 $5.71 $5.33 $6.05 $8.38 $9.51 $7.13 $5.24 $5.47
Weighted Average Basic Shares Outstanding
1.03B 1.00B 991M 970M 936M 921M 923M 916M 908M 912M 909M
Diluted Earnings per Share
$2.82 $3.48 $3.61 $5.59 $5.24 $5.97 $8.26 $9.41 $7.07 $5.20 $5.45
Weighted Average Diluted Shares Outstanding
1.04B 1.02B 1.01B 990M 952M 933M 936M 926M 916M 919M 913M
Weighted Average Basic & Diluted Shares Outstanding
1.01B 1.00B 991.60M 969.90M 933.98M 920.24M 923.55M 906.21M 909.29M 910.33M 907.55M
Cash Dividends to Common per Share
$1.40 - $2.12 $2.63 $3.21 $3.72 $4.21 $4.69 $5.02 $5.26 $5.50

Quarterly Income Statements for Texas Instruments

This table shows Texas Instruments' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Income / (Loss) Attributable to Common Shareholders
1,699 1,365 1,100 1,121 1,355 1,199 1,173 1,288 1,356 1,156 1,536
Consolidated Net Income / (Loss)
1,709 1,371 1,105 1,127 1,362 1,205 1,179 1,295 1,364 1,163 1,545
Net Income / (Loss) Continuing Operations
1,709 1,371 1,105 1,127 1,362 1,205 1,179 1,295 1,364 1,163 1,545
Total Pre-Tax Income
1,922 1,548 1,293 1,247 1,554 1,359 1,276 1,478 1,584 1,372 1,714
Total Operating Income
1,892 1,533 1,286 1,248 1,554 1,377 1,324 1,563 1,663 1,473 1,808
Total Gross Profit
2,815 2,431 2,095 2,211 2,474 2,314 2,313 2,575 2,723 2,472 2,799
Total Revenue
4,532 4,077 3,661 3,822 4,151 4,007 4,069 4,448 4,742 4,423 4,825
Operating Revenue
4,532 4,077 3,661 3,822 4,151 4,007 4,069 4,448 4,742 4,423 4,825
Total Cost of Revenue
1,717 1,646 1,566 1,611 1,677 1,693 1,756 1,873 2,019 1,951 2,026
Operating Cost of Revenue
1,717 1,646 1,566 1,611 1,677 1,693 1,756 1,873 2,019 1,951 2,026
Total Operating Expenses
923 898 809 963 920 937 989 1,012 1,060 999 991
Selling, General & Admin Expense
452 438 455 465 428 446 472 485 457 446 464
Research & Development Expense
471 460 478 498 492 491 517 527 518 521 510
Restructuring Charge
0.00 - -124 0.00 0.00 - 0.00 0.00 85 32 17
Total Other Income / (Expense), net
30 15 7.00 -1.00 0.00 -18 -48 -85 -79 -101 -94
Interest Expense
98 98 116 131 131 130 128 133 141 141 141
Other Income / (Expense), net
128 113 123 130 131 112 80 48 62 40 47
Income Tax Expense
213 177 188 120 192 154 97 183 220 209 169
Preferred Stock Dividends Declared
10 6.00 5.00 6.00 7.00 6.00 6.00 7.00 8.00 7.00 9.00
Basic Earnings per Share
$1.87 $1.50 $1.21 $1.23 $1.48 $1.32 $1.29 $1.42 $1.49 $1.27 $1.69
Weighted Average Basic Shares Outstanding
908M 908M 910M 912M 913M 912M 910M 908M 909M 909M 909M
Diluted Earnings per Share
$1.85 $1.50 $1.20 $1.22 $1.47 $1.31 $1.28 $1.41 $1.48 $1.28 $1.68
Weighted Average Diluted Shares Outstanding
916M 916M 917M 919M 920M 919M 916M 912M 914M 913M 914M
Weighted Average Basic & Diluted Shares Outstanding
908.20M 909.29M 910.48M 913.05M 912.22M 910.33M 908.47M 909.14M 908.62M 907.55M 910.09M
Cash Dividends to Common per Share
$1.24 - $1.30 $1.30 - - $1.36 $1.36 - - $1.42

Annual Cash Flow Statements for Texas Instruments

This table details how cash moves in and out of Texas Instruments' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
-199 154 502 782 -1.00 670 1,524 -1,581 -86 236 25
Net Cash From Operating Activities
4,397 4,614 5,363 7,189 6,649 6,139 8,756 8,720 6,420 6,318 7,153
Net Cash From Continuing Operating Activities
4,397 4,614 5,366 7,189 6,649 6,139 8,756 8,720 6,420 6,318 7,153
Net Income / (Loss) Continuing Operations
2,986 3,595 3,682 5,580 5,017 5,595 7,769 8,749 6,510 4,799 5,001
Consolidated Net Income / (Loss)
2,986 3,595 3,682 5,580 5,017 5,595 7,769 8,749 6,510 4,799 5,001
Depreciation Expense
766 605 539 590 708 733 755 925 1,175 1,508 1,918
Amortization Expense
367 350 365 364 342 259 199 54 63 72 81
Non-Cash Adjustments To Reconcile Net Income
201 212 242 229 194 220 173 286 362 260 421
Changes in Operating Assets and Liabilities, net
100 -148 538 426 388 -668 -140 -1,294 -1,690 -321 -268
Net Cash From Investing Activities
-302 -650 -1,127 -78 -1,920 -922 -4,095 -3,583 -4,362 -3,202 -1,439
Net Cash From Continuing Investing Activities
-302 -650 -1,127 -78 -1,920 -922 -4,095 -3,583 -4,362 -3,202 -1,439
Purchase of Property, Plant & Equipment
-551 -531 -695 -1,131 -847 -649 -2,462 -2,797 -5,071 -4,820 -4,550
Purchase of Investments
-2,767 -3,503 -4,555 -5,641 -3,444 -5,786 -10,124 -14,483 -12,705 -9,716 -3,524
Sale of Property, Plant & Equipment
110 0.00 40 9.00 30 4.00 75 3.00 3.00 195 1.00
Sale and/or Maturity of Investments
2,892 3,390 4,095 6,708 2,309 5,545 8,478 13,657 13,387 11,187 6,308
Other Investing Activities, net
14 -6.00 -12 -23 32 -36 -62 37 24 -48 326
Net Cash From Financing Activities
-4,294 -3,810 -3,734 -6,329 -4,730 -4,547 -3,137 -6,718 -2,144 -2,880 -5,689
Net Cash From Continuing Financing Activities
-4,294 -3,810 -3,734 -6,329 -4,730 -4,547 -3,137 -6,718 -2,144 -2,880 -5,689
Repayment of Debt
-1,003 -1,003 -656 -547 -792 -536 -596 -541 -557 -653 -812
Repurchase of Common Equity
-2,741 -2,132 -2,556 -5,100 -2,960 -2,553 -527 -3,615 -293 -929 -1,477
Payment of Dividends
-1,444 -1,646 -2,104 -2,555 -3,008 -3,426 -3,886 -4,297 -4,557 -4,795 -4,999
Issuance of Debt
498 499 1,099 1,500 1,491 1,498 1,495 1,494 3,000 2,980 1,199
Issuance of Common Equity
396 472 483 373 539 470 377 241 263 517 400

Quarterly Cash Flow Statements for Texas Instruments

This table details how cash moves in and out of Texas Instruments' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Change in Cash & Equivalents
-873 398 -481 257 -151 611 -437 281 267 -86 324
Net Cash From Operating Activities
1,937 1,924 1,017 1,571 1,732 1,998 849 1,860 2,190 2,254 1,520
Net Cash From Continuing Operating Activities
1,937 1,924 1,017 1,571 1,732 1,998 849 1,860 2,190 2,254 1,520
Net Income / (Loss) Continuing Operations
1,709 1,371 1,105 1,127 1,362 1,205 1,179 1,295 1,364 1,163 1,545
Consolidated Net Income / (Loss)
1,709 1,371 1,105 1,127 1,362 1,205 1,179 1,295 1,364 1,163 1,545
Depreciation Expense
303 322 346 363 383 416 424 460 497 537 541
Amortization Expense
17 15 16 18 19 19 20 21 20 20 21
Non-Cash Adjustments To Reconcile Net Income
79 69 -23 119 87 77 116 129 93 83 104
Changes in Operating Assets and Liabilities, net
-171 147 -427 -56 -119 281 -890 -45 216 451 -691
Net Cash From Investing Activities
-1,694 -311 -3,329 - -487 614 1,253 -1,335 -681 -676 -47
Net Cash From Continuing Investing Activities
-1,694 -311 -3,329 - -487 614 1,253 -1,335 -681 -676 -47
Purchase of Property, Plant & Equipment
-1,495 -1,148 -1,248 -1,064 -1,316 -1,192 -1,123 -1,305 -1,197 -925 -676
Purchase of Investments
-3,080 -2,565 -4,864 -2,098 -1,845 -909 -647 -1,192 -805 -880 -935
Sale of Property, Plant & Equipment
1.00 - 192 2.00 - 1.00 0.00 - 1.00 - 5.00
Sale and/or Maturity of Investments
2,885 3,411 2,631 3,130 2,700 2,726 2,807 1,131 1,260 1,110 1,043
Other Investing Activities, net
-5.00 -9.00 -40 30 -26 -12 216 31 60 19 516
Net Cash From Financing Activities
-1,116 -1,215 1,831 -1,314 -1,396 -2,001 -2,539 -244 -1,242 -1,664 -1,149
Net Cash From Continuing Financing Activities
-1,116 -1,215 1,831 -1,314 -1,396 -2,001 -2,539 -244 -1,242 -1,664 -1,149
Repayment of Debt
-12 -14 -28 -306 -8.00 -311 -766 -21 -12 -13 -9.00
Repurchase of Common Equity
-46 -65 -3.00 -71 -318 -537 -653 -302 -119 -403 -158
Payment of Dividends
-1,126 -1,181 -1,183 -1,185 -1,187 -1,240 -1,238 -1,235 -1,236 -1,290 -1,291
Issuance of Common Equity
68 45 65 248 117 87 118 115 125 42 309

Annual Balance Sheets for Texas Instruments

This table presents Texas Instruments' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets
16,230 16,431 17,642 17,137 18,018 19,351 24,676 27,207 32,348 35,509 34,585
Total Current Assets
7,074 7,457 8,734 8,097 8,761 10,239 13,685 14,021 15,122 15,026 13,750
Cash & Equivalents
1,000 1,154 1,656 2,438 2,437 3,107 4,631 3,050 2,964 3,200 3,225
Short-Term Investments
2,218 2,336 2,813 1,795 2,950 3,461 5,108 6,017 5,611 4,380 1,656
Accounts Receivable
1,165 1,267 1,278 1,207 1,074 1,414 1,701 1,895 1,787 1,719 1,963
Inventories, net
1,691 1,790 1,957 2,217 2,001 1,955 1,910 2,757 3,999 4,527 4,804
Prepaid Expenses
1,000 910 1,030 440 299 302 335 302 761 1,200 2,102
Plant, Property, & Equipment, net
2,596 2,512 2,664 3,183 3,303 3,269 5,141 6,876 9,999 11,347 12,320
Plant, Property & Equipment, gross
5,465 4,923 4,789 5,425 5,740 5,781 7,858 9,950 13,268 15,254 17,682
Accumulated Depreciation
2,869 2,411 2,125 2,242 2,437 2,512 2,717 3,074 3,269 3,907 5,362
Total Noncurrent Assets
6,560 6,462 6,244 5,857 5,954 5,843 5,850 6,310 7,227 9,136 8,515
Goodwill
4,362 4,362 4,362 4,362 4,362 4,362 4,362 4,362 4,362 4,362 4,330
Intangible Assets
1,629 1,316 1,056 717 409 122 85 152 223 257 238
Noncurrent Deferred & Refundable Income Taxes
201 374 264 295 197 343 263 473 757 936 967
Employee Benefit Assets
85 96 208 92 218 246 392 188 173 233 324
Other Noncurrent Operating Assets
62 79 86 140 468 770 748 1,135 1,712 3,348 2,656
Total Liabilities & Shareholders' Equity
16,230 16,431 17,642 17,137 18,018 19,351 24,676 27,207 32,348 35,509 34,585
Total Liabilities
6,284 5,958 7,305 8,143 9,111 10,164 11,343 12,630 15,451 18,606 18,312
Total Current Liabilities
2,555 2,264 2,258 2,474 2,123 2,390 2,569 2,985 3,320 3,643 3,159
Short-Term Debt
1,000 631 500 749 500 550 500 500 599 750 500
Accounts Payable
386 396 466 478 388 415 571 851 802 820 756
Current Deferred & Payable Income Tax Liabilities
95 83 128 103 46 134 121 189 172 159 67
Current Employee Benefit Liabilities
664 710 722 724 714 767 775 799 836 839 829
Other Current Liabilities
410 444 442 420 475 524 602 646 911 1,075 1,007
Total Noncurrent Liabilities
3,729 3,694 5,047 5,669 6,988 7,774 8,774 9,645 12,131 14,963 15,153
Long-Term Debt
3,120 2,978 3,577 4,319 5,303 6,248 7,241 8,235 10,624 12,846 13,548
Noncurrent Deferred & Payable Income Tax Liabilities
37 33 78 42 78 90 87 66 63 53 66
Noncurrent Employee Benefit Liabilities
196 129 89 118 93 131 79 118 108 110 124
Other Noncurrent Operating Liabilities
- 554 1,303 1,190 1,514 1,305 1,367 1,226 1,336 1,954 1,415
Total Equity & Noncontrolling Interests
9,946 10,473 10,337 8,994 8,907 9,187 13,333 14,577 16,897 16,903 16,273
Total Preferred & Common Equity
9,946 10,473 10,337 8,994 8,907 9,187 13,333 14,577 16,897 16,903 16,273
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
9,946 10,473 10,337 8,994 8,907 9,187 13,333 14,577 16,897 16,903 16,273
Common Stock
3,370 3,415 3,517 3,691 3,851 4,074 4,371 4,692 5,103 5,676 6,252
Retained Earnings
31,176 33,107 34,662 37,906 39,898 42,051 45,919 50,353 52,283 52,262 52,236
Treasury Stock
-24,068 -25,523 -27,458 -32,130 -34,495 -36,578 -36,800 -40,214 -40,284 -40,895 -42,130
Accumulated Other Comprehensive Income / (Loss)
-532 -526 -384 -473 -347 -360 -157 -254 -205 -140 -85

Quarterly Balance Sheets for Texas Instruments

This table presents Texas Instruments' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026
Period end date 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026
Total Assets
30,939 31,638 32,348 34,885 35,048 35,321 35,509 33,757 34,933 35,004 34,393
Total Current Assets
15,514 15,097 15,122 17,448 16,789 15,872 15,026 13,086 14,484 13,876 13,796
Cash & Equivalents
3,439 2,566 2,964 2,483 2,740 2,589 3,200 2,763 3,044 3,311 3,549
Short-Term Investments
6,113 6,382 5,611 7,910 6,948 6,163 4,380 2,242 2,315 1,875 1,554
Accounts Receivable
1,956 1,976 1,787 1,671 1,711 1,862 1,719 1,860 1,934 2,062 2,245
Inventories, net
3,729 3,908 3,999 4,083 4,106 4,296 4,527 4,687 4,812 4,829 4,695
Prepaid Expenses
277 265 761 1,301 1,284 962 1,200 1,534 2,379 1,799 1,753
Plant, Property, & Equipment, net
8,525 9,320 9,999 10,442 11,174 11,802 11,347 11,811 12,321 12,348 12,145
Plant, Property & Equipment, gross
11,664 12,528 13,268 13,739 14,622 15,464 15,254 16,036 16,878 17,314 17,870
Accumulated Depreciation
3,139 3,208 3,269 3,297 3,448 3,662 3,907 4,225 4,557 4,966 5,725
Total Noncurrent Assets
6,900 7,221 7,227 6,995 7,085 7,647 9,136 8,860 8,128 8,780 8,452
Goodwill
4,362 4,362 4,362 4,362 4,362 4,362 4,362 4,362 4,362 4,362 4,330
Intangible Assets
143 138 223 231 230 229 257 263 248 237 323
Noncurrent Deferred & Refundable Income Taxes
537 632 757 821 905 941 936 1,030 1,096 1,089 973
Employee Benefit Assets
183 166 173 169 167 184 233 240 253 251 321
Other Noncurrent Operating Assets
1,675 1,923 1,712 1,412 1,421 1,931 3,348 2,965 2,169 2,841 2,505
Total Liabilities & Shareholders' Equity
30,939 31,638 32,348 34,885 35,048 35,321 35,509 33,757 34,933 35,004 34,393
Total Liabilities
14,999 15,007 15,451 17,902 17,834 18,053 18,606 17,351 18,530 18,377 17,615
Total Current Liabilities
2,711 2,652 3,320 3,553 3,637 3,686 3,643 2,489 2,492 3,118 3,096
Short-Term Debt
299 300 599 1,349 1,049 1,049 750 0.00 0.00 500 1,149
Accounts Payable
923 713 802 551 858 794 820 866 881 779 638
Current Deferred & Payable Income Tax Liabilities
121 108 172 378 178 108 159 284 53 79 138
Current Employee Benefit Liabilities
561 707 836 399 569 721 839 418 595 724 389
Other Current Liabilities
807 824 911 876 983 1,014 1,075 921 963 1,036 782
Total Noncurrent Liabilities
12,288 12,355 12,131 14,349 14,197 14,367 14,963 14,862 16,038 15,259 14,519
Long-Term Debt
10,920 10,922 10,624 12,840 12,842 12,844 12,846 12,848 14,043 13,546 12,901
Noncurrent Deferred & Payable Income Tax Liabilities
69 66 63 55 55 54 53 56 63 60 63
Noncurrent Employee Benefit Liabilities
127 141 108 111 113 117 110 115 122 125 121
Other Noncurrent Operating Liabilities
1,172 1,226 1,336 1,343 1,187 1,352 1,954 1,843 1,810 1,528 1,434
Total Equity & Noncontrolling Interests
15,940 16,631 16,897 16,983 17,214 17,268 16,903 16,406 16,403 16,627 16,778
Total Preferred & Common Equity
15,940 16,631 16,897 16,983 17,214 17,268 16,903 16,406 16,403 16,627 16,778
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
15,940 16,631 16,897 16,983 17,214 17,268 16,903 16,406 16,403 16,627 16,778
Common Stock
4,904 5,021 5,103 5,180 5,407 5,554 5,676 5,799 5,986 6,151 6,463
Retained Earnings
51,522 52,098 52,283 52,199 52,135 52,304 52,262 52,196 52,249 52,369 52,483
Treasury Stock
-40,240 -40,253 -40,284 -40,193 -40,128 -40,395 -40,895 -41,442 -41,676 -41,744 -42,084
Accumulated Other Comprehensive Income / (Loss)
-246 -235 -205 -203 -200 -195 -140 -147 -156 -149 -84

Annual Metrics And Ratios for Texas Instruments

This table displays calculated financial ratios and metrics derived from Texas Instruments' official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-0.35% 2.85% 11.90% 5.50% -8.88% 0.54% 26.85% 9.18% -12.53% -10.72% 13.05%
EBITDA Growth
4.64% 9.67% 18.39% 9.95% -10.52% 3.61% 39.70% 11.61% -19.74% -16.29% 9.43%
EBIT Growth
8.52% 16.35% 22.91% 10.60% -13.40% 5.24% 46.66% 12.56% -24.16% -23.29% 4.90%
NOPAT Growth
6.50% 15.66% 4.05% 52.09% -10.53% 9.34% 42.41% 13.31% -27.25% -25.24% 9.68%
Net Income Growth
5.85% 20.40% 2.42% 51.55% -10.09% 11.52% 38.86% 12.61% -25.59% -26.28% 4.21%
EPS Growth
9.73% 23.40% 3.74% 54.85% -6.26% 13.93% 38.36% 13.92% -24.87% -26.45% 4.81%
Operating Cash Flow Growth
8.46% 4.94% 16.23% 34.05% -7.51% -7.67% 42.63% -0.41% -26.38% -1.59% 13.22%
Free Cash Flow Firm Growth
4.29% 3.26% 14.53% 30.65% -2.35% -8.64% 15.73% 0.79% -80.89% 26.63% 91.85%
Invested Capital Growth
-5.59% -2.54% -6.57% -1.02% -5.79% 4.37% 20.37% 25.67% 37.21% 17.26% 11.00%
Revenue Q/Q Growth
-0.61% 1.71% 2.30% -0.21% -2.49% 5.29% 4.30% -0.80% -3.27% -0.45% 2.41%
EBITDA Q/Q Growth
0.15% 5.69% 0.74% -0.09% -3.29% 10.19% 5.31% -2.05% -5.33% -0.78% 1.80%
EBIT Q/Q Growth
1.22% 7.63% 0.90% -0.47% -3.86% 12.16% 6.27% -2.71% -6.96% -2.57% 0.39%
NOPAT Q/Q Growth
1.24% 1.49% -13.48% 19.11% -3.60% 10.47% 8.09% -2.23% -8.68% -2.77% 0.54%
Net Income Q/Q Growth
0.37% 6.24% -16.03% 19.10% -3.26% 12.42% 6.15% -1.97% -8.32% -3.34% -0.83%
EPS Q/Q Growth
1.81% 6.75% -15.65% 19.44% -2.42% 12.64% 6.03% -1.36% -8.30% -3.53% -0.55%
Operating Cash Flow Q/Q Growth
2.93% -3.59% 11.24% 3.10% -5.55% 6.43% 2.72% -3.49% -1.80% 1.19% 3.71%
Free Cash Flow Firm Q/Q Growth
2.97% -7.35% 11.44% 5.96% -6.75% 5.42% -11.73% 2.31% -24.14% -0.48% 27.00%
Invested Capital Q/Q Growth
-4.70% -1.61% -10.97% -6.02% -4.22% -1.46% 12.14% 6.67% 3.39% 2.28% -0.18%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
58.27% 61.76% 64.26% 65.11% 63.71% 64.10% 67.47% 68.76% 62.90% 58.14% 57.02%
EBITDA Margin
41.84% 44.61% 47.20% 49.20% 48.31% 49.78% 54.82% 56.05% 51.42% 48.21% 46.67%
Operating Margin
33.25% 36.31% 40.66% 42.53% 39.79% 40.76% 48.84% 50.63% 41.85% 34.94% 34.06%
EBIT Margin
33.12% 37.47% 41.16% 43.15% 41.01% 42.92% 49.62% 51.16% 44.36% 38.11% 35.36%
Profit (Net Income) Margin
22.97% 26.89% 24.61% 35.35% 34.88% 38.69% 42.35% 43.68% 37.16% 30.68% 28.28%
Tax Burden Percent
70.83% 72.92% 60.56% 83.46% 87.59% 92.99% 87.11% 87.21% 87.76% 88.01% 87.58%
Interest Burden Percent
97.91% 98.40% 98.73% 98.16% 97.12% 96.94% 97.98% 97.91% 95.46% 91.48% 91.32%
Effective Tax Rate
29.17% 27.08% 39.44% 16.54% 12.41% 7.01% 12.89% 12.79% 12.24% 11.99% 12.42%
Return on Invested Capital (ROIC)
27.98% 33.74% 36.78% 58.19% 53.90% 59.44% 75.22% 69.14% 38.08% 22.65% 21.82%
ROIC Less NNEP Spread (ROIC-NNEP)
18.27% 53.10% 37.24% 117.49% 55.15% 125.55% 79.26% 77.23% 44.67% 22.41% 18.21%
Return on Net Nonoperating Assets (RNNOA)
1.39% 1.47% -1.39% -0.46% 2.16% 2.40% -6.22% -6.45% 3.29% 5.74% 8.33%
Return on Equity (ROE)
29.37% 35.21% 35.39% 57.73% 56.05% 61.84% 69.00% 62.69% 41.37% 28.40% 30.15%
Cash Return on Invested Capital (CROIC)
33.73% 36.32% 43.56% 59.22% 59.86% 55.17% 56.73% 46.39% 6.71% 6.76% 11.39%
Operating Return on Assets (OROA)
25.63% 30.68% 36.15% 39.17% 33.55% 33.22% 41.35% 39.50% 26.10% 17.57% 17.84%
Return on Assets (ROA)
17.77% 22.01% 21.61% 32.09% 28.54% 29.94% 35.29% 33.73% 21.86% 14.14% 14.27%
Return on Common Equity (ROCE)
29.37% 35.21% 35.39% 57.73% 56.05% 61.84% 69.00% 62.69% 41.37% 28.40% 30.15%
Return on Equity Simple (ROE_SIMPLE)
30.02% 34.33% 35.62% 62.04% 56.33% 60.90% 58.27% 60.02% 38.53% 28.39% 0.00%
Net Operating Profit after Tax (NOPAT)
3,061 3,540 3,684 5,603 5,013 5,481 7,805 8,843 6,434 4,810 5,275
NOPAT Margin
23.55% 26.48% 24.62% 35.50% 34.85% 37.90% 42.55% 44.15% 36.72% 30.75% 29.83%
Net Nonoperating Expense Percent (NNEP)
9.71% -19.36% -0.47% -59.30% -1.25% -66.11% -4.04% -8.08% -6.59% 0.24% 3.61%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - 37.93% 22.88% 15.77% 17.40%
Cost of Revenue to Revenue
41.73% 38.24% 35.74% 34.89% 36.29% 35.90% 32.53% 31.24% 37.10% 41.86% 42.98%
SG&A Expenses to Revenue
13.29% 13.03% 11.32% 10.67% 11.44% 11.39% 9.38% 8.51% 10.42% 11.47% 10.52%
R&D to Revenue
9.75% 10.14% 10.08% 9.88% 10.73% 10.58% 8.47% 8.34% 10.63% 12.52% 11.78%
Operating Expenses to Revenue
25.02% 25.45% 23.60% 22.58% 23.92% 23.34% 18.62% 18.13% 21.05% 23.20% 22.96%
Earnings before Interest and Taxes (EBIT)
4,306 5,010 6,158 6,811 5,898 6,207 9,103 10,246 7,771 5,961 6,253
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
5,439 5,965 7,062 7,765 6,948 7,199 10,057 11,225 9,009 7,541 8,252
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
4.41 5.64 8.27 8.60 11.79 14.79 12.05 9.63 8.84 10.05 9.62
Price to Tangible Book Value (P/TBV)
11.09 12.32 17.38 19.75 25.40 28.88 18.08 13.94 12.14 13.82 13.38
Price to Revenue (P/Rev)
3.37 4.42 5.71 4.90 7.30 9.39 8.76 7.01 8.53 10.86 8.86
Price to Earnings (P/E)
14.90 16.63 23.42 13.96 21.07 24.40 20.76 16.11 23.07 35.56 31.49
Dividend Yield
3.24% 2.77% 2.44% 3.27% 2.86% 2.51% 2.42% 3.03% 3.05% 2.83% 3.19%
Earnings Yield
6.71% 6.01% 4.27% 7.16% 4.75% 4.10% 4.82% 6.21% 4.33% 2.81% 3.18%
Enterprise Value to Invested Capital (EV/IC)
4.19 5.69 8.76 8.14 11.65 14.45 13.99 9.83 7.78 7.67 6.52
Enterprise Value to Revenue (EV/Rev)
3.43 4.41 5.67 4.94 7.31 9.41 8.65 6.99 8.68 11.24 9.38
Enterprise Value to EBITDA (EV/EBITDA)
8.19 9.88 12.01 10.03 15.13 18.90 15.77 12.47 16.88 23.31 20.09
Enterprise Value to EBIT (EV/EBIT)
10.34 11.77 13.77 11.44 17.83 21.92 17.43 13.66 19.57 29.49 26.51
Enterprise Value to NOPAT (EV/NOPAT)
14.55 16.65 23.02 13.91 20.98 24.83 20.32 15.83 23.64 36.55 31.43
Enterprise Value to Operating Cash Flow (EV/OCF)
10.13 12.78 15.82 10.84 15.81 22.16 18.12 16.05 23.69 27.83 23.18
Enterprise Value to Free Cash Flow (EV/FCFF)
12.07 15.47 19.44 13.67 18.89 26.75 26.95 23.59 134.14 122.47 60.19
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.41 0.34 0.39 0.56 0.65 0.74 0.58 0.60 0.66 0.80 0.86
Long-Term Debt to Equity
0.31 0.28 0.35 0.48 0.60 0.68 0.54 0.56 0.63 0.76 0.83
Financial Leverage
0.08 0.03 -0.04 0.00 0.04 0.02 -0.08 -0.08 0.07 0.26 0.46
Leverage Ratio
1.65 1.60 1.64 1.80 1.96 2.07 1.96 1.86 1.89 2.01 2.11
Compound Leverage Factor
1.62 1.57 1.62 1.77 1.91 2.00 1.92 1.82 1.81 1.84 1.93
Debt to Total Capital
29.29% 25.63% 28.29% 36.04% 39.45% 42.53% 36.73% 37.47% 39.91% 44.58% 46.33%
Short-Term Debt to Total Capital
7.11% 4.48% 3.47% 5.33% 3.40% 3.44% 2.37% 2.14% 2.13% 2.46% 1.65%
Long-Term Debt to Total Capital
22.18% 21.15% 24.82% 30.71% 36.05% 39.09% 34.36% 35.33% 37.78% 42.12% 44.68%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
70.71% 74.37% 71.72% 63.96% 60.55% 57.47% 63.27% 62.53% 60.09% 55.42% 53.67%
Debt to EBITDA
0.76 0.61 0.58 0.65 0.84 0.94 0.77 0.78 1.25 1.80 1.70
Net Debt to EBITDA
0.13 -0.02 -0.09 0.08 0.02 0.03 -0.20 -0.03 0.29 0.80 1.11
Long-Term Debt to EBITDA
0.57 0.50 0.51 0.56 0.76 0.87 0.72 0.73 1.18 1.70 1.64
Debt to NOPAT
1.35 1.02 1.11 0.90 1.16 1.24 0.99 0.99 1.74 2.83 2.66
Net Debt to NOPAT
0.22 -0.03 -0.18 0.10 0.02 0.04 -0.26 -0.04 0.41 1.25 1.74
Long-Term Debt to NOPAT
1.02 0.84 0.97 0.77 1.06 1.14 0.93 0.93 1.65 2.67 2.57
Altman Z-Score
8.89 10.97 12.21 11.42 12.34 13.35 13.60 11.72 9.84 8.92 8.72
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
2.77 3.29 3.87 3.27 4.13 4.28 5.33 4.70 4.55 4.12 4.35
Quick Ratio
1.72 2.10 2.55 2.20 3.04 3.34 4.45 3.67 3.12 2.55 2.17
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
3,690 3,810 4,364 5,702 5,568 5,087 5,887 5,933 1,134 1,436 2,754
Operating Cash Flow to CapEx
997.05% 868.93% 818.78% 640.73% 813.83% 951.78% 366.82% 312.10% 126.68% 136.61% 157.24%
Free Cash Flow to Firm to Interest Expense
41.00 47.63 55.95 45.61 32.75 26.77 31.99 27.73 3.21 2.83 5.07
Operating Cash Flow to Interest Expense
48.86 57.68 68.76 57.51 39.11 32.31 47.59 40.75 18.19 12.44 13.17
Operating Cash Flow Less CapEx to Interest Expense
43.96 51.04 60.36 48.54 34.31 28.92 34.61 27.69 3.83 3.33 4.80
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.77 0.82 0.88 0.91 0.82 0.77 0.83 0.77 0.59 0.46 0.50
Accounts Receivable Turnover
10.78 11.00 11.76 12.70 12.61 11.62 11.78 11.14 9.52 8.92 9.60
Inventory Turnover
3.12 2.94 2.85 2.64 2.47 2.62 3.09 2.68 1.92 1.54 1.63
Fixed Asset Turnover
4.78 5.23 5.78 5.40 4.44 4.40 4.36 3.33 2.08 1.47 1.49
Accounts Payable Turnover
13.18 13.08 12.41 11.67 12.05 12.93 12.11 8.80 7.86 8.07 9.64
Days Sales Outstanding (DSO)
33.85 33.20 31.04 28.73 28.94 31.40 30.99 32.77 38.36 40.91 38.00
Days Inventory Outstanding (DIO)
116.90 124.25 127.89 138.32 147.50 139.05 118.19 136.12 189.69 237.67 224.10
Days Payable Outstanding (DPO)
27.69 27.91 29.42 31.28 30.28 28.23 30.15 41.48 46.41 45.21 37.85
Cash Conversion Cycle (CCC)
123.06 129.53 129.51 135.77 146.16 142.23 119.03 127.42 181.63 233.36 224.25
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
10,627 10,357 9,677 9,578 9,023 9,417 11,335 14,245 19,545 22,919 25,440
Invested Capital Turnover
1.19 1.27 1.49 1.64 1.55 1.57 1.77 1.57 1.04 0.74 0.73
Increase / (Decrease) in Invested Capital
-629 -270 -680 -99 -555 394 1,918 2,910 5,300 3,374 2,521
Enterprise Value (EV)
44,534 58,954 84,816 77,917 105,150 136,070 158,627 139,990 152,067 175,810 165,782
Market Capitalization
43,853 59,070 85,476 77,333 105,034 135,840 160,625 140,322 149,419 169,794 156,615
Book Value per Share
$9.80 $10.48 $10.49 $9.36 $9.53 $10.01 $14.44 $16.06 $18.60 $18.53 $17.91
Tangible Book Value per Share
$3.90 $4.80 $4.99 $4.08 $4.42 $5.12 $9.62 $11.09 $13.56 $13.47 $12.88
Total Capital
14,066 14,082 14,414 14,062 14,710 15,985 21,074 23,312 28,120 30,499 30,321
Total Debt
4,120 3,609 4,077 5,068 5,803 6,798 7,741 8,735 11,223 13,596 14,048
Total Long-Term Debt
3,120 2,978 3,577 4,319 5,303 6,248 7,241 8,235 10,624 12,846 13,548
Net Debt
681 -116 -660 584 116 230 -1,998 -332 2,648 6,016 9,167
Capital Expenditures (CapEx)
441 531 655 1,122 817 645 2,387 2,794 5,068 4,625 4,549
Debt-free, Cash-free Net Working Capital (DFCFNWC)
2,301 2,334 2,507 2,139 1,751 1,831 1,877 2,469 3,826 4,553 6,210
Debt-free Net Working Capital (DFNWC)
5,519 5,824 6,976 6,372 7,138 8,399 11,616 11,536 12,401 12,133 11,091
Net Working Capital (NWC)
4,519 5,193 6,476 5,623 6,638 7,849 11,116 11,036 11,802 11,383 10,591
Net Nonoperating Expense (NNE)
75 -55 1.82 23 -4.38 -114 36 94 -76 11 274
Net Nonoperating Obligations (NNO)
681 -116 -660 584 116 230 -1,998 -332 2,648 6,016 9,167
Total Depreciation and Amortization (D&A)
1,133 955 904 954 1,050 992 954 979 1,238 1,580 1,999
Debt-free, Cash-free Net Working Capital to Revenue
17.70% 17.46% 16.76% 13.55% 12.17% 12.66% 10.23% 12.33% 21.84% 29.11% 35.12%
Debt-free Net Working Capital to Revenue
42.45% 43.56% 46.63% 40.37% 49.63% 58.08% 63.32% 57.60% 70.79% 77.57% 62.72%
Net Working Capital to Revenue
34.76% 38.84% 43.29% 35.62% 46.15% 54.28% 60.60% 55.10% 67.37% 72.78% 59.90%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.00 $0.00 $0.00 $0.00 $5.33 $6.05 $8.38 $9.51 $7.13 $5.24 $5.47
Adjusted Weighted Average Basic Shares Outstanding
0.00 0.00 0.00 0.00 936M 921M 923M 916M 908M 912M 909M
Adjusted Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $5.24 $5.97 $8.26 $9.41 $7.07 $5.20 $5.45
Adjusted Weighted Average Diluted Shares Outstanding
0.00 0.00 0.00 0.00 952M 933M 936M 926M 916M 919M 913M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 0.00 0.00 0.00 933.98M 920.24M 923.55M 906.21M 909.29M 910.33M 907.55M
Normalized Net Operating Profit after Tax (NOPAT)
3,244 3,762 3,883 5,870 4,981 5,481 7,805 9,067 6,434 4,700 5,378
Normalized NOPAT Margin
24.95% 28.14% 25.95% 37.19% 34.63% 37.90% 42.55% 45.27% 36.72% 30.05% 30.41%
Pre Tax Income Margin
32.43% 36.87% 40.64% 42.36% 39.82% 41.61% 48.62% 50.09% 42.34% 34.86% 32.29%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
47.84 62.63 78.95 54.49 34.69 32.67 49.47 47.88 22.01 11.73 11.52
NOPAT to Interest Expense
34.01 44.25 47.23 44.82 29.49 28.85 42.42 41.32 18.23 9.47 9.71
EBIT Less CapEx to Interest Expense
42.94 55.99 70.55 45.51 29.89 29.27 36.50 34.82 7.66 2.63 3.14
NOPAT Less CapEx to Interest Expense
29.11 37.62 38.83 35.84 24.68 25.45 29.44 28.27 3.87 0.36 1.34
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
48.36% 45.79% 57.14% 45.79% 59.96% 61.23% 50.02% 49.11% 70.00% 99.92% 99.96%
Augmented Payout Ratio
140.15% 105.09% 126.56% 137.19% 118.96% 106.86% 56.80% 90.43% 74.50% 119.27% 129.49%

Quarterly Metrics And Ratios for Texas Instruments

This table displays calculated financial ratios and metrics derived from Texas Instruments' official financial filings.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
DEI Shares Outstanding
- - - - - - - - - - 907,550,774.00
DEI Adjusted Shares Outstanding
- - - - - - - - - - 907,550,774.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - - - 1.69
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-13.53% -12.70% -16.40% -15.65% -8.41% -1.72% 11.14% 16.38% 14.24% 10.38% 18.58%
EBITDA Growth
-21.29% -20.36% -22.83% -26.43% -10.81% -2.98% 4.35% 18.93% 7.43% 7.59% 30.79%
EBIT Growth
-25.49% -26.09% -30.04% -34.10% -16.58% -9.54% -0.35% 16.91% 2.37% 1.61% 32.12%
NOPAT Growth
-27.24% -31.09% -35.26% -33.50% -19.04% -10.07% 11.31% 21.42% 5.14% 2.27% 33.22%
Net Income Growth
-25.53% -30.12% -35.30% -34.55% -20.30% -12.11% 6.70% 14.91% 0.15% -3.49% 31.04%
EPS Growth
-25.10% -29.91% -35.14% -34.76% -20.54% -12.67% 6.67% 15.57% 0.68% -2.29% 31.25%
Operating Cash Flow Growth
-29.97% -5.78% -12.33% 12.29% -10.58% 3.85% -16.52% 18.40% 26.44% 12.81% 79.03%
Free Cash Flow Firm Growth
-314.32% -319.46% -75.87% 9.44% 44.63% 45.39% 41.74% 14.23% 23.16% 40.90% 106.84%
Invested Capital Growth
41.57% 37.21% 31.31% 21.64% 18.53% 17.26% 16.70% 17.14% 13.74% 11.00% 6.09%
Revenue Q/Q Growth
0.02% -10.04% -10.20% 4.40% 8.61% -3.47% 1.55% 9.31% 6.61% -6.73% 9.09%
EBITDA Q/Q Growth
-2.13% -15.26% -10.69% -0.68% 18.65% -7.81% -3.95% 13.20% 7.17% -7.67% 16.76%
EBIT Q/Q Growth
-3.40% -18.51% -14.40% -2.20% 22.28% -11.63% -5.71% 14.74% 7.08% -12.29% 22.60%
NOPAT Q/Q Growth
-0.82% -19.30% -19.05% 2.63% 20.76% -10.36% 0.20% 11.94% 4.57% -12.81% 30.52%
Net Income Q/Q Growth
-0.75% -19.78% -19.40% 1.99% 20.85% -11.53% -2.16% 9.84% 5.33% -14.74% 32.85%
EPS Q/Q Growth
-1.07% -18.92% -20.00% 1.67% 20.49% -10.88% -2.29% 10.16% 4.96% -13.51% 31.25%
Operating Cash Flow Q/Q Growth
38.46% -0.67% -47.14% 54.47% 10.25% 15.36% -57.51% 119.08% 17.74% 2.92% -32.56%
Free Cash Flow Firm Q/Q Growth
-30.62% -1.90% 2.19% 30.44% 20.14% -0.52% -4.35% -2.40% 28.45% 22.70% 112.08%
Invested Capital Q/Q Growth
7.37% 3.39% 6.31% 3.07% 4.63% 2.28% 5.80% 3.46% 1.59% -0.18% 1.12%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
62.11% 59.63% 57.22% 57.85% 59.60% 57.75% 56.84% 57.89% 57.42% 55.89% 58.01%
EBITDA Margin
51.63% 48.64% 48.37% 46.02% 50.28% 48.02% 45.42% 47.03% 47.28% 46.80% 50.09%
Operating Margin
41.75% 37.60% 35.13% 32.65% 37.44% 34.36% 32.54% 35.14% 35.07% 33.30% 37.47%
EBIT Margin
44.57% 40.37% 38.49% 36.05% 40.59% 37.16% 34.50% 36.22% 36.38% 34.21% 38.45%
Profit (Net Income) Margin
37.71% 33.63% 30.18% 29.49% 32.81% 30.07% 28.98% 29.11% 28.76% 26.29% 32.02%
Tax Burden Percent
88.92% 88.57% 85.46% 90.38% 87.64% 88.67% 92.40% 87.62% 86.11% 84.77% 90.14%
Interest Burden Percent
95.15% 94.05% 91.77% 90.49% 92.23% 91.27% 90.88% 91.74% 91.83% 90.68% 92.40%
Effective Tax Rate
11.08% 11.43% 14.54% 9.62% 12.36% 11.33% 7.60% 12.38% 13.89% 15.23% 9.86%
Return on Invested Capital (ROIC)
41.68% 34.53% 27.56% 24.34% 24.96% 22.45% 21.43% 22.08% 21.77% 20.64% 24.92%
ROIC Less NNEP Spread (ROIC-NNEP)
46.44% 35.68% 27.83% 24.31% 24.96% 22.08% 20.67% 20.92% 20.80% 19.52% 23.91%
Return on Net Nonoperating Assets (RNNOA)
1.67% 2.63% 3.78% 4.30% 5.46% 5.66% 7.21% 8.02% 8.59% 8.93% 12.10%
Return on Equity (ROE)
43.36% 37.16% 31.34% 28.64% 30.41% 28.11% 28.64% 30.10% 30.36% 29.58% 37.02%
Cash Return on Invested Capital (CROIC)
9.26% 6.71% 4.81% 7.47% 6.98% 6.76% 6.50% 6.47% 9.06% 11.39% 16.83%
Operating Return on Assets (OROA)
27.98% 23.75% 20.17% 17.58% 19.05% 17.13% 16.13% 17.26% 17.86% 17.26% 20.80%
Return on Assets (ROA)
23.68% 19.78% 15.82% 14.38% 15.40% 13.86% 13.55% 13.87% 14.12% 13.27% 17.33%
Return on Common Equity (ROCE)
43.36% 37.16% 31.34% 28.64% 30.41% 28.11% 28.64% 30.10% 30.36% 29.58% 37.02%
Return on Equity Simple (ROE_SIMPLE)
42.70% 0.00% 34.78% 30.86% 28.75% 0.00% 29.70% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
1,682 1,358 1,099 1,128 1,362 1,221 1,223 1,369 1,432 1,249 1,630
NOPAT Margin
37.12% 33.30% 30.02% 29.51% 32.81% 30.47% 30.07% 30.79% 30.20% 28.23% 33.78%
Net Nonoperating Expense Percent (NNEP)
-4.76% -1.15% -0.27% 0.03% 0.00% 0.37% 0.76% 1.16% 0.97% 1.13% 1.01%
Return On Investment Capital (ROIC_SIMPLE)
- 4.83% - - - 4.00% 4.18% 4.50% 4.67% 4.12% 5.29%
Cost of Revenue to Revenue
37.89% 40.37% 42.78% 42.15% 40.40% 42.25% 43.16% 42.11% 42.58% 44.11% 41.99%
SG&A Expenses to Revenue
9.97% 10.74% 12.43% 12.17% 10.31% 11.13% 11.60% 10.90% 9.64% 10.08% 9.62%
R&D to Revenue
10.39% 11.28% 13.06% 13.03% 11.85% 12.25% 12.71% 11.85% 10.92% 11.78% 10.57%
Operating Expenses to Revenue
20.37% 22.03% 22.10% 25.20% 22.16% 23.38% 24.31% 22.75% 22.35% 22.59% 20.54%
Earnings before Interest and Taxes (EBIT)
2,020 1,646 1,409 1,378 1,685 1,489 1,404 1,611 1,725 1,513 1,855
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
2,340 1,983 1,771 1,759 2,087 1,924 1,848 2,092 2,242 2,070 2,417
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
8.42 8.84 9.19 10.22 10.92 10.05 9.97 11.50 10.05 9.62 10.50
Price to Tangible Book Value (P/TBV)
11.54 12.14 12.60 13.94 14.88 13.82 13.89 15.99 13.89 13.38 14.53
Price to Revenue (P/Rev)
7.73 8.53 9.29 10.94 12.00 10.86 10.19 11.31 9.67 8.86 9.56
Price to Earnings (P/E)
19.82 23.07 26.55 33.30 38.17 35.56 33.74 37.61 33.30 31.49 33.02
Dividend Yield
3.22% 3.05% 2.96% 2.66% 2.52% 2.83% 2.96% 2.59% 2.96% 3.19% 2.86%
Earnings Yield
5.05% 4.33% 3.77% 3.00% 2.62% 2.81% 2.96% 2.66% 3.00% 3.18% 3.03%
Enterprise Value to Invested Capital (EV/IC)
7.53 7.78 7.69 8.41 8.65 7.67 7.07 7.86 6.90 6.52 7.20
Enterprise Value to Revenue (EV/Rev)
7.86 8.68 9.52 11.20 12.33 11.24 10.68 11.83 10.19 9.38 10.04
Enterprise Value to EBITDA (EV/EBITDA)
14.95 16.88 18.84 22.94 25.49 23.31 22.50 24.81 21.70 20.09 20.99
Enterprise Value to EBIT (EV/EBIT)
17.04 19.57 22.31 27.92 31.67 29.49 28.78 31.88 28.24 26.51 27.62
Enterprise Value to NOPAT (EV/NOPAT)
20.20 23.64 27.40 34.21 39.17 36.55 34.75 38.12 33.53 31.43 32.59
Enterprise Value to Operating Cash Flow (EV/OCF)
21.76 23.69 25.47 27.94 31.03 27.83 27.87 30.64 25.50 23.18 23.66
Enterprise Value to Free Cash Flow (EV/FCFF)
95.22 134.14 181.58 123.67 134.31 122.47 117.17 131.07 81.11 60.19 44.03
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.67 0.66 0.84 0.81 0.80 0.80 0.78 0.86 0.84 0.86 0.84
Long-Term Debt to Equity
0.66 0.63 0.76 0.75 0.74 0.76 0.78 0.86 0.81 0.83 0.77
Financial Leverage
0.04 0.07 0.14 0.18 0.22 0.26 0.35 0.38 0.41 0.46 0.51
Leverage Ratio
1.85 1.89 1.99 1.99 1.98 2.01 2.06 2.08 2.07 2.11 2.05
Compound Leverage Factor
1.76 1.78 1.83 1.80 1.82 1.83 1.87 1.91 1.91 1.92 1.90
Debt to Total Capital
40.29% 39.91% 45.52% 44.66% 44.58% 44.58% 43.92% 46.12% 45.79% 46.33% 45.58%
Short-Term Debt to Total Capital
1.08% 2.13% 4.33% 3.37% 3.37% 2.46% 0.00% 0.00% 1.63% 1.65% 3.73%
Long-Term Debt to Total Capital
39.21% 37.78% 41.19% 41.29% 41.22% 42.12% 43.92% 46.12% 44.16% 44.68% 41.85%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
59.71% 60.09% 54.48% 55.34% 55.42% 55.42% 56.08% 53.88% 54.21% 53.67% 54.42%
Debt to EBITDA
1.18 1.25 1.67 1.77 1.83 1.80 1.69 1.77 1.73 1.70 1.59
Net Debt to EBITDA
0.24 0.29 0.45 0.54 0.68 0.80 1.03 1.09 1.09 1.11 1.01
Long-Term Debt to EBITDA
1.15 1.18 1.51 1.64 1.69 1.70 1.69 1.77 1.67 1.64 1.46
Debt to NOPAT
1.59 1.74 2.43 2.64 2.81 2.83 2.60 2.71 2.68 2.66 2.47
Net Debt to NOPAT
0.32 0.41 0.65 0.80 1.04 1.25 1.59 1.68 1.69 1.74 1.58
Long-Term Debt to NOPAT
1.55 1.65 2.20 2.44 2.60 2.67 2.60 2.71 2.58 2.57 2.27
Altman Z-Score
9.16 9.21 8.42 9.04 9.36 8.50 8.81 9.24 8.57 8.27 9.23
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
5.69 4.55 4.91 4.62 4.31 4.12 5.26 5.81 4.45 4.35 4.46
Quick Ratio
4.12 3.12 3.40 3.13 2.88 2.55 2.76 2.93 2.32 2.17 2.37
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-3,869 -3,942 -3,856 -2,682 -2,142 -2,153 -2,247 -2,301 -1,646 -1,272 154
Operating Cash Flow to CapEx
129.65% 167.60% 96.31% 147.93% 131.61% 167.76% 75.60% 142.53% 183.11% 243.68% 226.53%
Free Cash Flow to Firm to Interest Expense
-39.48 -40.23 -33.24 -20.47 -16.35 -16.56 -17.55 -17.30 -11.67 -9.02 1.09
Operating Cash Flow to Interest Expense
19.77 19.63 8.77 11.99 13.22 15.37 6.63 13.99 15.53 15.99 10.78
Operating Cash Flow Less CapEx to Interest Expense
4.52 7.92 -0.34 3.89 3.18 6.21 -2.14 4.17 7.05 9.43 6.02
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.63 0.59 0.52 0.49 0.47 0.46 0.47 0.48 0.49 0.50 0.54
Accounts Receivable Turnover
9.02 9.52 9.47 8.78 8.19 8.92 9.09 9.15 8.80 9.60 8.98
Inventory Turnover
2.04 1.92 1.78 1.67 1.58 1.54 1.54 1.57 1.61 1.63 1.68
Fixed Asset Turnover
2.29 2.08 1.86 1.63 1.49 1.47 1.44 1.42 1.43 1.49 1.54
Accounts Payable Turnover
8.62 7.86 8.72 7.34 8.63 8.07 9.51 8.05 9.33 9.64 10.46
Days Sales Outstanding (DSO)
40.47 38.36 38.54 41.59 44.58 40.91 40.15 39.89 41.48 38.00 40.63
Days Inventory Outstanding (DIO)
178.96 189.69 205.38 218.64 230.34 237.67 237.57 232.54 226.85 224.10 217.59
Days Payable Outstanding (DPO)
42.33 46.41 41.88 49.70 42.31 45.21 38.39 45.34 39.11 37.85 34.88
Cash Conversion Cycle (CCC)
177.09 181.63 202.04 210.53 232.61 233.36 239.34 227.09 229.22 224.25 223.34
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
18,905 19,545 20,779 21,417 22,409 22,919 24,249 25,087 25,487 25,440 25,725
Invested Capital Turnover
1.12 1.04 0.92 0.82 0.76 0.74 0.71 0.72 0.72 0.73 0.74
Increase / (Decrease) in Invested Capital
5,551 5,300 4,955 3,810 3,504 3,374 3,470 3,670 3,078 2,521 1,476
Enterprise Value (EV)
142,291 152,067 159,866 180,174 193,749 175,810 171,430 197,301 175,896 165,782 185,139
Market Capitalization
140,017 149,419 156,070 175,971 188,608 169,794 163,587 188,617 167,036 156,615 176,192
Book Value per Share
$18.32 $18.60 $18.66 $18.91 $18.91 $18.53 $18.02 $18.06 $18.29 $17.91 $18.49
Tangible Book Value per Share
$13.36 $13.56 $13.62 $13.86 $13.88 $13.47 $12.94 $12.98 $13.23 $12.88 $13.36
Total Capital
27,853 28,120 31,172 31,105 31,161 30,499 29,254 30,446 30,673 30,321 30,828
Total Debt
11,222 11,223 14,189 13,891 13,893 13,596 12,848 14,043 14,046 14,048 14,050
Total Long-Term Debt
10,922 10,624 12,840 12,842 12,844 12,846 12,848 14,043 13,546 13,548 12,901
Net Debt
2,274 2,648 3,796 4,203 5,141 6,016 7,843 8,684 8,860 9,167 8,947
Capital Expenditures (CapEx)
1,494 1,148 1,056 1,062 1,316 1,191 1,123 1,305 1,196 925 671
Debt-free, Cash-free Net Working Capital (DFCFNWC)
3,797 3,826 4,851 4,513 4,483 4,553 5,592 6,633 6,072 6,210 6,746
Debt-free Net Working Capital (DFNWC)
12,745 12,401 15,244 14,201 13,235 12,133 10,597 11,992 11,258 11,091 11,849
Net Working Capital (NWC)
12,445 11,802 13,895 13,152 12,186 11,383 10,597 11,992 10,758 10,591 10,700
Net Nonoperating Expense (NNE)
-27 -13 -5.98 0.90 0.00 16 44 74 68 86 85
Net Nonoperating Obligations (NNO)
2,274 2,648 3,796 4,203 5,141 6,016 7,843 8,684 8,860 9,167 8,947
Total Depreciation and Amortization (D&A)
320 337 362 381 402 435 444 481 517 557 562
Debt-free, Cash-free Net Working Capital to Revenue
20.96% 21.84% 28.87% 28.05% 28.53% 29.11% 34.84% 39.78% 35.17% 35.12% 36.59%
Debt-free Net Working Capital to Revenue
70.37% 70.79% 90.73% 88.25% 84.24% 77.57% 66.03% 71.92% 65.20% 62.72% 64.26%
Net Working Capital to Revenue
68.71% 67.37% 82.70% 81.73% 77.56% 72.78% 66.03% 71.92% 62.31% 59.90% 58.03%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$1.87 $1.50 $1.21 $1.23 $1.48 $1.32 $1.29 $1.42 $1.49 $1.27 $1.69
Adjusted Weighted Average Basic Shares Outstanding
908M 908M 910M 912M 913M 912M 910M 908M 909M 909M 909M
Adjusted Diluted Earnings per Share
$1.85 $1.50 $1.20 $1.22 $1.47 $1.31 $1.28 $1.41 $1.48 $1.28 $1.68
Adjusted Weighted Average Diluted Shares Outstanding
916M 916M 917M 919M 920M 919M 916M 912M 914M 913M 914M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
908.20M 909.29M 910.48M 913.05M 912.22M 910.33M 908.47M 909.14M 908.62M 907.55M 910.09M
Normalized Net Operating Profit after Tax (NOPAT)
1,682 1,358 993 1,128 1,362 1,221 1,223 1,369 1,505 1,276 1,645
Normalized NOPAT Margin
37.12% 33.30% 27.13% 29.51% 32.81% 30.47% 30.07% 30.79% 31.74% 28.84% 34.09%
Pre Tax Income Margin
42.41% 37.97% 35.32% 32.63% 37.44% 33.92% 31.36% 33.23% 33.40% 31.02% 35.52%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
20.61 16.80 12.15 10.52 12.86 11.45 10.97 12.11 12.23 10.73 13.16
NOPAT to Interest Expense
17.17 13.85 9.47 8.61 10.40 9.39 9.56 10.30 10.16 8.86 11.56
EBIT Less CapEx to Interest Expense
5.37 5.08 3.04 2.41 2.82 2.29 2.20 2.30 3.75 4.17 8.40
NOPAT Less CapEx to Interest Expense
1.92 2.14 0.37 0.50 0.35 0.23 0.78 0.48 1.67 2.30 6.80
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
63.36% 70.00% 78.13% 88.01% 95.39% 99.92% 99.53% 97.20% 98.14% 99.96% 94.13%
Augmented Payout Ratio
78.51% 74.50% 81.40% 91.49% 104.59% 119.27% 131.93% 133.11% 130.08% 129.49% 112.43%

Financials Breakdown Chart

Key Financial Trends

Texas Instruments (TXN) has demonstrated solid cash generation and stable profitability across recent quarters, with some leverage and near-term profitability nuances. Below are the key takeaways based on the last four years of quarterly statements.

  • Strong quarterly operating cash flow persists. Net cash from continuing operating activities in Q4 2025 was about $2.254B, up from roughly $2.0B in Q4 2024, signaling improving cash generation.
  • Profitability remains robust on a gross-margin basis. Gross margins have stayed in the mid-50s to high-50s range in recent quarters (Q4 2025 gross profit $2.472B on $4.423B revenue ≈ 55.8%; Q3 2025 ≈ 57.3%; Q2 2025 ≈ 57.9%; Q1 2025 ≈ 56.9%).
  • Consistent quarterly dividends support income-focused investors. The quarterly dividend per share is $1.36 in 2025, indicating stable cash returns to shareholders.
  • R&D remains a meaningful, ongoing investment. R&D spend runs around $0.5B per quarter in 2025 (Q4 2025 $521M; Q3 2025 $518M; Q2 2025 $527M; Q1 2025 $517M), underpinning long-term growth potential.
  • Revenue stayed in a stable, high-4B range in 2025 after a dip in 2023. Quarterly revenue generally hovered around $4.0–$4.7B (e.g., Q4 2025 $4.423B; Q3 2025 $4.742B; Q2 2025 $4.448B; Q1 2025 $4.069B), suggesting resilience in core operations.
  • Leverage remains elevated but manageable alongside cash generation. Long-term debt around $13.5B and total liabilities near $18.4B as of 2025Q3, signaling substantial leverage but with healthy operating cash flow to support obligations.
  • Capital spending is meaningful but within a predictable range. Quarterly purchases of property, plant & equipment run roughly $0.9B–$1.3B (e.g., 2025 Q4 PPE outflow around $0.925B; Q3 around $1.197B; Q2 around $1.305B; Q1 around $1.128B), consistent with capacity maintenance and expansion.
  • Near-term profitability per share shows some volatility. Net income attributable to common shareholders in Q4 2025 was about $1.156B, modestly below the ~$1.199B recorded in Q4 2024.
  • Financing activities remain cash-out heavy at times. 2025 included sizable financing outflows (e.g., net cash from financing activities around -$1.664B in Q4 2025) with notable share repurchases (~$403M in Q4 2025) and maintained dividend payments.
  • Debt load continues to loom over liquidity considerations. With long-term debt around $13.5B and total liabilities near $18.4B in mid-2025, the company carries a substantial leverage burden relative to cash generation.
05/09/26 10:17 AM ETAI Generated. May Contain Errors.

Texas Instruments Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Texas Instruments' fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

Texas Instruments' net income appears to be on an upward trend, with a most recent value of $5.00 billion in 2025, rising from $2.99 billion in 2015. The previous period was $4.80 billion in 2024. See where experts think Texas Instruments is headed by visiting Texas Instruments' forecast page.

Texas Instruments' total operating income in 2025 was $6.02 billion, based on the following breakdown:
  • Total Gross Profit: $10.08 billion
  • Total Operating Expenses: $4.06 billion

Over the last 10 years, Texas Instruments' total revenue changed from $13 billion in 2015 to $17.68 billion in 2025, a change of 36.0%.

Texas Instruments' total liabilities were at $18.31 billion at the end of 2025, a 1.6% decrease from 2024, and a 191.4% increase since 2015.

In the past 10 years, Texas Instruments' cash and equivalents has ranged from $1 billion in 2015 to $4.63 billion in 2021, and is currently $3.23 billion as of their latest financial filing in 2025.

Over the last 10 years, Texas Instruments' book value per share changed from 9.80 in 2015 to 17.91 in 2025, a change of 82.7%.



Financial statements for NASDAQ:TXN last updated on 4/28/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners